StockData
BlossomHill Therapeutics, Inc. logo

BlossomHill Therapeutics, Inc. (BLSM) SEC filings

BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.02−0.82 (-5.53%)

Close on Nov 13, 2026Market cap $35.73MP/E –Yield –

SEC filings

6 of BlossomHill Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 12, 2026SEC EDGAR
Current report8-KNov 12, 2026Nov 12, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Sep 18, 2026SEC EDGAR
Current report8-KSep 18, 2026Sep 18, 2026SEC EDGAR
Current report8-KSep 15, 2026Sep 15, 2026SEC EDGAR
Current report8-KAug 10, 2026Aug 10, 2026SEC EDGAR

See a number that looks wrong?